Description
An LPL activator that increases LPL mRNA and LPL activity in adipose tissue, myocardium, and skeletal muscle; decreases plasma triglyceride concentration and increases plasma high-density lipoprotein cholesterol, resulting in inhibited development of atherosclerotic lesions in coronary arteries and aortas of rats and rabbits
Formal name: [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-phosphonic acid diethyl ester
Synonyms: Ibrolipim|Lipoprotein Lipase Activator|LPL Activator|OPF 009
Molecular weight: 451.3
CAS: 133208-93-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Activators||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Lipid Biochemistry|Sterol Lipids